Summary of Significant Accounting Policies (Tables)

6 Months Ended

Dec. 31, 2023

Accounting Policies [Abstract]

Schedule of Net Revenue Disaggregated by Product and Region

The following table summarizes our net revenue disaggregated by segment, product and region (in thousands):

	Three Months Ended December 31,				Six Months Ended December 31,
	2023		2022		2023		2022
U.S., Canada and Latin America
Devices	$	371,336	$	345,525	$	717,233	$	685,070
Masks and other	297,994		269,733		590,455		508,293
Total U.S., Canada and Latin America	$	669,330	$	615,258	$	1,307,688	$	1,193,363
Combined Europe, Asia and other markets
Devices	$	234,661	$	197,275	$	453,492	$	375,305
Masks and other	113,864		104,448		219,712		192,756
Total Combined Europe, Asia and other markets	$	348,525	$	301,723	$	673,204	$	568,061
Global revenue
Total Devices	$	605,997	$	542,800	$	1,170,725	$	1,060,375
Total Masks and other	411,858		374,181		810,167		701,049
Total Sleep and Respiratory Care	$	1,017,855	$	916,981	$	1,980,892	$	1,761,424
Software as a Service	144,946		116,763		284,230		222,614
Total	$	1,162,801	$	1,033,744	$	2,265,122	$	1,984,038

Schedule of Contract Balances

The following table summarizes our contract balances (in thousands):

	December 31, 2023		June 30, 2023		Balance sheet caption
Contract assets
Accounts receivable, net	$	729,740	$	704,909	Accounts receivable, net
Unbilled revenue, current	34,577		31,521		Prepaid expenses and other current assets
Unbilled revenue, non-current	10,844		10,078		Prepaid taxes and other non-current assets
Contract liabilities
Deferred revenue, current	(148,897)		(138,072)		Deferred revenue (current liabilities)
Deferred revenue, non-current	(127,410)		(119,186)		Deferred revenue (non-current liabilities)